We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Savella Launch Delayed for FDA to Approve Color Change
Savella Launch Delayed for FDA to Approve Color Change
March 13, 2009
The March introduction of Forest Laboratories’ fibromyalgia drug Savella has been delayed until mid-year as the company waits for the FDA to approve a change in the color of a set of tablets in a four-week titration pack.